Cost of acid peptic disorders in a managed-care organization

Clinical Therapeutics

Volumn 18, Issue 2, 1996, Pages 319-333

  Segal, Richard ^a,f   Russell, Wayne L ^a,b   Ben Joseph, Rami ^c   Mansheim, Bernard ^d,e  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c NOVA SOUTHEASTERN UNIVERSITY   (United States)

^d AvMed Health Plan   (United States)

^e HealthSpring Inc   (United States)

^f UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIULCER AGENT; CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; NIZATIDINE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; AMBULATORY CARE; ARTICLE; CONTROLLED STUDY; COST; DRUG COST; ENDOSCOPY; FEMALE; HEALTH CARE ORGANIZATION; HEALTH MAINTENANCE ORGANIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MANAGEMENT; MEDICAL FEE; MEDICAL SPECIALIST; PEPTIC ULCER; PRIMARY MEDICAL CARE; TECHNIQUE; TREATMENT OUTCOME; UNITED STATES;

EID: 0029995451     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(96)80013-0     Document Type: Article

References (23)

1. Schondelmeyer SW. Trends with third parties and managed care: A pharmacy perspective. Presented at a symposium entitled "The Changing Health Care Environment: Its Impact on Pharmacy and the Pharmaceutical Industry." November 11-14, 1987: Indianapolis, Ind.
2. Study suggests cause and cure for ulcers. The Wall Street Journal. 1992;May 1:B1.
3. Lampkin TA, Ouellet D, Hak LJ, et al. Omeprazole: A novel antisecretory agent for the treatment of acid-peptic disorders. DICP Ann Pharmacother. 1990;24: 393-402.
4. Walan A, Bader JP, Classen M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. NEJM. 1989;320:69-75.
5. Lauritsen K, Rune SJ, Wulff H, et al. Effect of omeprazole and cimetidine on prepyloric gastric ulcer: Double blind comparative trial. Gut. 1988;29:249-253.
6. Classen M, Dammann HG, Domschke W, et al. Omeprazole heals duodenal but not gastric ulcers more rapidly than ranitidine: Results of two German multicentre trials. Hepatogastroenterology. 1985;32:243-245.
7. Lauritsen K, Rune SJ, Bytzer P, et al. Effect of omeprazole and cimetidine on duodenal ulcer: A double-blind comparative trial. NEJM. 1985;312:958-961.
8. Bradhan KD, Bianchi-Porro G, Daly M, et al. A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol. 1986;8:408-413.
9. Archambault A, Pare P, Bailey RJ, et al. Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief. Gastroenterology. 1988;94:1130-1134.
10. Classen M, Dammann HG, Domschke W, et al. Kurzzeittherapie desulcus duodeni mit omeprazol and ranitidin. Dtsch Med Wochenschr. 1985;110:210-215.
11. Havelund T, Laursen LS, Skoubo-Kristensen E, et al. Omeprazole and ranitidine in treatment of reflux oesophagitis: Double blind comparative trial. BMJ. 1988; 296:89-92.
12. Sandmark S, Carlsson R, Fausa O, et al. Omeprazole or ranitidine in the treatment of reflux esophagitis: Results of a double-blind, randomized Scandinavian multicenter study. Scand J Gastroenterol. 1988; 23:625-632.
13. Vantruppen G, Rutgeerts L, Schurmans P, et al. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis. Dig Dis Sci. 1988;33:523-529.
14. Bate CM. Cost effectiveness of omeprazole in the treatment of reflux oesophagitis. Br J Med Econ. 1991;1:53-61.
15. Bate CM. Omeprazole vs ranitidine and cimetidine in reflux oesophagitis. Pharmacoeconomics. 1994;5(Suppl 3):35-43.
16. 2-receptor antagonists. Br J Med Econ. 1992;2:37-48.
17. Bate CM, Richardson PD. A one year model for the cost-effectiveness of treating reflux oesophagitis. Br J Med Econ. 1992;2:5-11.
18. Hillman AL, Bloom BS, Fendrick AM, Schwartz JS. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease. Arch Intern Med. 1992;152:1467-1472.
19. Jönsson B, Drummond MF, Stålhammar N. Cost-effectiveness of omeprazole and ranitidine in the treatment of duodenal ulcer. Pharmacoeconomics. 1994;5(Suppl 3):44-55.
20. Appropriate Use of Gastrointestinal Endoscopy. A Consensus Statement from the American Society for Gastrointestinal Endoscopy. Manchester, Mass: American Society for Gastrointestinal Endoscopy; May 1989.
21. 2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet. 1994;343: 811-816.
22. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA. 1994;272:65-69.
23. Fendrick AM, Chernew ME, Hirth RA, et al. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med. 1995;123:260-268.